KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Retained Earnings (2016 - 2026)

Abbott Laboratories' Retained Earnings history spans 18 years, with the latest figure at $50.0 billion for Q1 2026.

  • On a quarterly basis, Retained Earnings rose 4.7% to $50.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $50.0 billion, a 4.7% increase, with the full-year FY2025 number at -$6.0 billion, down 112.7% from a year prior.
  • Retained Earnings hit $50.0 billion in Q1 2026 for Abbott Laboratories, up from -$6.0 billion in the prior quarter.
  • Over the last five years, Retained Earnings for ABT hit a ceiling of $50.0 billion in Q1 2026 and a floor of -$8.5 billion in Q3 2023.
  • Historically, Retained Earnings has averaged $21.8 billion across 5 years, with a median of $35.1 billion in 2022.
  • Biggest five-year swings in Retained Earnings: crashed 129.56% in 2022 and later skyrocketed 702.9% in 2024.
  • Tracing ABT's Retained Earnings over 5 years: stood at -$8.1 billion in 2022, then increased by 2.63% to -$7.8 billion in 2023, then soared by 702.9% to $47.3 billion in 2024, then plummeted by 112.7% to -$6.0 billion in 2025, then skyrocketed by 932.46% to $50.0 billion in 2026.
  • Business Quant data shows Retained Earnings for ABT at $50.0 billion in Q1 2026, -$6.0 billion in Q4 2025, and $49.1 billion in Q3 2025.